3,327 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Acquired by Cary Street Partners Financial LLC

Cary Street Partners Financial LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 3,327 shares of the company’s stock, valued at approximately $219,000.

Other large investors have also recently added to or reduced their stakes in the company. Atala Financial Inc bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth about $25,000. Union Bancaire Privee UBP SA acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at $42,000. Capital Analysts LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 41.8% in the fourth quarter. Capital Analysts LLC now owns 1,575 shares of the company’s stock valued at $104,000 after buying an additional 464 shares during the last quarter. Comerica Bank lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 23.1% during the fourth quarter. Comerica Bank now owns 2,466 shares of the company’s stock worth $162,000 after purchasing an additional 462 shares in the last quarter. Finally, Runnymede Capital Advisors Inc. bought a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $164,000.

iShares U.S. Pharmaceuticals ETF Stock Down 1.5 %

Shares of IHE stock opened at $63.74 on Friday. The firm has a market cap of $548.16 million, a price-to-earnings ratio of 23.46 and a beta of 0.63. iShares U.S. Pharmaceuticals ETF has a 12 month low of $58.97 and a 12 month high of $73.28. The stock has a 50-day moving average price of $66.79 and a 200 day moving average price of $67.91.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.